Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Fierce Pharma
JANUARY 25, 2023
Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16 Moderna now in the crosshairs of Sens.
tag pricing 
Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line
Fierce Pharma
NOVEMBER 23, 2022
price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. Sporting a $3.5M Wed, 11/23/2022 - 10:10.
FDA 
121
121 FDA 121
121 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Can gene therapies for haemophilia defend their high price tags?
Pharmaceutical Technology
NOVEMBER 9, 2022
Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. A previous October 2020 report concluded that longer-term safety and efficacy were needed to update health-benefit price benchmarks.
FDA 111
111 FDA 111
111 
Amylyx ALS drug draws criticism over $158,000 price tag
pharmaphorum
OCTOBER 3, 2022
Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 per year in the US, sparking outcry. ALS affects over 30,000 people in the US.
Insurance 52
52 
Orchard’s MLD gene therapy becomes costliest US medicine
pharmaphorum
MARCH 20, 2024
Orchard Therapeutics has revealed the US price of Lenmeldy, its gene therapy for rare disease MLD, placing a $4.25m price tag on the one-shot treatment
106 
Oncology Drug Pipeline to Rollout New Treatments, But Not Without Hefty Price Tag
Drug Topics
NOVEMBER 3, 2023
During a session at AMCP Nexus, presenters discussed the delicate balance between cost and innovation as it relates to forthcoming oncology treatments.
98 
Orchard sets new gene therapy price tag at $4.25M—the steepest of any drug in the US
Fierce Pharma
MARCH 20, 2024
Kyowa Kirin and its subsidiary Orchard Therapeutics have broken new boundaries in pricing, too. After scoring an FDA nod Monday for the first gene therapy to treat the rare genetic disease metachromatic leukodystrophy (MLD) in the U.S.,
FDA 104
104 FDA 104
104 
FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag
pharmaphorum
JUNE 8, 2021
.” Biogen meanwhile has been taking flak over its decision to price Aduhelm at $56,000 per year, which looks set to re-ignite debate in the US about the cost of medicines. Aside from the high price, another issue is its dosing by monthly infusion, as clinics that can provide this are not available in all areas. billion in 2027.
FDA 98
98 
Not covering emerging Alzheimer's drugs could cost Medicare billions: study
Fierce Healthcare
JUNE 9, 2023
Emerging Alzheimer’s disease medications come with high price tags, but researchers with the University of Chicago calculate that in the long run, it’s much less costly to cover these therapies for | Emerging Alzheimer’s medications come with high price tags, but researchers with the University of Chicago calculate that in the long run, it’s much less (..)
145 
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Pharmaceutical Technology
APRIL 25, 2024
A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.
52 
STAT+: Steward Health Care has deal to sell doctor network to UnitedHealth
STAT
MARCH 26, 2024
A price tag was not included in documents filed with the state, and Optum officials did not immediately respond to comment. On Tuesday, a subsidiary of Optum, Collaborative Care Holdings, LLC, filed notice with the state’s Health Policy Commission over the sale. Continue to STAT+ to read the full story…
Hospitals 132
132 
Widespread Implementation of Long-Acting PrEP for HIV May Be Stifled By High Price Tag, Say Researchers
Pharmacy Times
DECEMBER 12, 2022
Following the approval of cabotegravir in 2021, governments and donor agencies in low- and middle-income countries are contemplating replacing oral pre-exposure prophylaxis or augmenting the approach with long-acting treatment.
123 
Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene Therapies
Pharmacy Times
APRIL 17, 2023
Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”
123 
Novelist John Green launches attack on Cepheid over the price of its TB test
STAT
SEPTEMBER 14, 2023
The diagnostics company Cepheid and the price of its tuberculosis test, GeneXpert. But in a scathing YouTube video posted Tuesday, Green argued the price is prohibitive for patients in lower-income countries. But in a scathing YouTube video posted Tuesday, Green argued the price is prohibitive for patients in lower-income countries.
137 
ICER updates cost-effectiveness threshold for bluebird, Vertex and CRISPR's dueling sickle cell gene therapies
Fierce Pharma
JULY 14, 2023
The potentially curative promise of gene therapies often carries a steep price tag. | The potentially curative promise of gene therapies often carries a steep price tag. But for a pair of personalized medicine prospects in sickle cell disease (SCD), the cost could be worth it, at least as far as ICER is concerned.
79 
STAT+: CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies
STAT
JANUARY 30, 2024
In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. government on Tuesday announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments. million and $3.1
128 
Revolutionizing Rare Disease Treatment: Embracing the Patient-Centric Transformation in Pharmaceutical Customer Engagement
Pharmaceutical Commerce
MARCH 6, 2024
Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag.
59 
STAT+: Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
STAT
APRIL 12, 2024
Often, these treatments — which target small patient populations of 200,000 or less people — carry high price tags, which the pharmaceutical industry argues simply reflects large investments for testing and development. Continue to STAT+ to read the full story…
104 
STAT+: Pharmalittle: We’re reading about a Senate probe into Novo pricing, a new UTI antibiotic, and more
STAT
APRIL 25, 2024
Senate Committee on Health, Education, Labor and Pensions is investigating the prices Novo Nordisk charges for its blockbuster medications, Ozempic and Wegovy, which are highly effective at treating diabetes and obesity but carry steep price tags, The New York Times writes. Bernie Sanders (I-Vt.), Bernie Sanders (I-Vt.),
Packaging 87
87 Packaging 87
87 
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
NOVEMBER 7, 2023
One potential advantage for bluebird, giving the timing, could be a chance to view its rival's pricing before deciding itself. But on Tuesday bluebird said that Vertex’s price tag will not factor into how the Massachusetts company will price its treatment.
FDA 85
85 FDA 85
85 
FDA approves Duchenne gene therapy with hefty $3.2m price tag
Pharmaceutical Technology
JUNE 23, 2023
Sarepta will now need to complete a confirmatory trial to prove the therapy improves physical function and mobility.
FDA 52
52 FDA 52
52 
Here are 22 health systems billing patients for certain EHR and text messages
Fierce Healthcare
AUGUST 16, 2023
As a result, at least 22 systems across the country have added a price tag to the subset of missives demanding the most time and expertise. Online messages have become a linchpin of many patients’ relationships with their doctors. | An influx of patient portal messages during recent years are taking a toll on clinicians.
98 
Rethink Medication Adherence With Sustainable Multidose Packaging
Drug Topics
OCTOBER 4, 2022
Medication nonadherence carries a $500 billion price tag in the United States.
Packaging 98
98 Packaging 98
98 
Pharma Pulse 3/29/24: Super Micro’s AI Boom Carries a Big Price Tag, Leveraging Digital Tools to Optimize Manufacturing & more
PharmExec
MARCH 29, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
52 
STAT+: Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy
STAT
OCTOBER 5, 2023
Kyowa Kirin is paying $16 per share — a nearly 100% premium on Orchard’s Wednesday closing price — in cash, amounting to roughly $390 million. LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in a $400 million deal, the companies said Thursday.
100 
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
STAT
MARCH 10, 2023
By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products. But neither factor has much effect, the studies concluded.
92 
STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages
STAT
OCTOBER 27, 2022
Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies. Continue to STAT+ to read the full story…
Dosage 102
102 Dosage 102
102 
Opinion: Sickle cell cures are coming. African children can’t be left behind
STAT
JULY 12, 2023
A potential cure that could save them from severe illness and early death will exist — but its expected multimillion-dollar price tag will be far out of reach. But for those with sickle cell in sub-Saharan Africa, where more than 60% of the 120 million people worldwide live with this disease, there is little cause to celebrate.
92 
Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies
STAT
JUNE 1, 2023
But executives at four health systems using the software, called DAX, told STAT that while the software might make it possible to see more patients, or justify higher charges to insurers for visits, the high price tag means it’s certainly not boosting their bottom lines. Read the rest…
Hospitals 98
98 
Coherus plans Humira biosimilar sale at 85% discount
Pharmaceutical Technology
JULY 14, 2023
Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s price tag of $6,922 for the same quantity.
52 
STAT+: Lawmakers tell Pfizer CEO to ‘back off’ on planned price hike for Covid-19 vaccine
STAT
DECEMBER 13, 2022
argued the planned price tag is nearly four times the current $30 price paid by the U.S. A pair of U.S. ” In their letter, U.S. Elizabeth Warren (D-Mass.) Peter Welch (D-Vt.) government and also represents a 10,000% markup over what some researchers have calculated as the cost to produce the vaccine.
Vaccines 89
89 Vaccines 89
89 
bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies
Pharmaceutical Technology
SEPTEMBER 30, 2022
Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. bluebird then broke its own pricing record when the $3m Skysona was approved, and now faces the unique challenge of selling the world's two most expensive drugs.
FDA 115
115 
STAT+: The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
STAT
JANUARY 6, 2023
Such decisions are based on myriad factors, starting with the average $26,500 price tag. Food and Drug Administration has granted accelerated approval to the widely anticipated Alzheimer’s drug from Eisai and Biogen, a key question is the extent to which payers — private and public — will cover the treatment.
FDA 97
97 FDA 97
97 
The best SingleCare reviews of 2023
The Checkup by Singlecare
DECEMBER 8, 2023
We’re here to help you get the best prices at the pharmacy, just like we did for these customers! RELATED: Health insurance statistics 2023 Unfortunately, rising healthcare costs mean higher drug prices and even copays are harder to afford. SingleCare’s prescription savings card is for everyone—regardless of insurance status.
Insurance 105
105 
STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease
STAT
DECEMBER 12, 2023
These drugs have price tags of $2.2 The news comes as researchers are still processing the Food and Drug Administration’s landmark approval of two cutting-edge sickle cell therapies, one made by Vertex Pharmaceuticals and CRISPR Therapeutics and the other by Bluebird Bio. million and $3.1 million, respectively.
Chemotherapy 115
115 
Haemophilia drug costing $3.5m per dose has been approved
Pharmafile
NOVEMBER 23, 2022
CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. Costing $3.5m per dose, the one-off infusion therapy has become the world’s most expensive medicine currently available.
72 
STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap
STAT
MARCH 10, 2023
Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two
66 
How much is Mounjaro without insurance?
The Checkup by Singlecare
AUGUST 31, 2023
Mounjaro can only be purchased at a premium price. Mounjaro can only be purchased as a premium-priced brand-name drug. Without insurance coverage, the list price for a 28-day supply of Mounjaro (4, 0.5 A year of Mounjaro treatment will cost nearly $19,000 at the full retail price. mL of 5 mg/0.5 mL of 5 mg/0.5
Insurance 98
98 
US Government Purchases 66 Million Doses of Moderna’s COVID-19 Booster Candidate
Pharmaceutical Commerce
AUGUST 1, 2022
Price tag for bivalent dose was $1.74 billion.
59 
STAT+: Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more
STAT
JANUARY 31, 2024
In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. Overall, Novo saw 154% growth in obesity drug revenue in 2023, driven by sales of its older obesity drug Saxenda and the launch of Wegovy in additional countries.
85 
Cost of disease-modifying therapies for multiple sclerosis continues to rise in US
Pharmaceutical Technology
MAY 19, 2023
DMTs for MS have a high price tag, particularly in the US. A similar trend of price increases was also seen for MS generics and biosimilars. However, they cannot provide a cure and have a very limited impact on halting disease progression.
98 
Risk-sharing agreements are growing at a rate of 24%
Pharmaceutical Technology
FEBRUARY 10, 2023
On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.
FDA 105
105 FDA 105
105 
STAT+: Pharmalittle: Vertex exec says prices for gene therapies are ‘in the ballpark’; insulin access in poor countries remains spotty
STAT
OCTOBER 6, 2022
… Multimillion-dollar prices for a rival’s treatments with the potential to cure rare diseases are “in the right ballpark,” according to Stuart Arbuckle, chief operating officer at Vertex Pharmaceuticals, which is preparing to market its own treatment for sickle-cell disease , Bloomberg News tells us. Even
74 
Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA
pharmaphorum
DECEMBER 24, 2021
The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease. The $56,000-a-year price tag for the drug, which has now been cut in half in the US, also hasn’t helped the drugmakers make a case for Aduhelm with US payers.
FDA 110
110 FDA 110
110 
Let's personalize your content